Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CryoCor begins AF (atrial fibrillation) cryotherapy trial:

This article was originally published in Clinica

Executive Summary

The US FDA has given CryoCor the go-ahead to begin a feasibility study of its minimally invasive cardiac cryoablation system for treating atrial fibrillation (AF). The study will involve around 30 patients at up to five centres and will assess the San Diego, California firm's system, called CryoCor, as a treatment for paroxysmal, or intermittent, AF. Patient follow-up of the trial is scheduled for completion by the fourth quarter of 2002, after which CryoCor plans to file for FDA approval to begin a pivotal US trial to support a marketing application for the device. The device has yet to be CE-marked for sale in Europe.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel